Hooikoortstabletten Loratadine Htp

Hooikoortstabletten Loratadine Htp is an oral tablet containing the antihistamine loratadine; the specific strength is not disclosed. It is marketed in the European Union as an over‑the‑counter (OTC) medication. The product belongs to the second‑generation H1‑receptor antagonist class and is formulated for systemic absorption after swallowing.

Hooikoortstabletten Loratadine Htp is indicated for the relief of symptoms caused by allergic conditions. It is commonly used in everyday practice for:

- Seasonal allergic rhinitis (hay fever) with sneezing, nasal congestion, and itching. - Perennial allergic rhinitis triggered by indoor allergens. - Seasonal allergic conjunctivitis causing itchy, watery eyes. - Chronic idiopathic urticaria (hives) with persistent skin itching and wheals. - Relief of mild to moderate allergic skin reactions such as insect bites.

Adverse reactions to Hooikoortstabletten Loratadine Htp are generally mild, but serious events can occur rarely.

Common: - Headache - Dry mouth - Fatigue or drowsiness (less common than first‑generation antihistamines) - Nausea or abdominal discomfort - Mild dizziness

Serious: - Severe skin rash or Stevens‑Johnson syndrome - Anaphylaxis or severe hypersensitivity reactions - Hepatotoxicity (elevated liver enzymes) - Cardiac arrhythmias in patients with pre‑existing conditions

Before using Hooikoortstabletten Loratadine Htp, consider the following precautions:

- Assess liver function in patients with known hepatic impairment. - Use cautiously in individuals with renal insufficiency; dosage adjustment may be required. - Avoid use in pregnant or breastfeeding women unless clearly indicated by a healthcare professional. - Monitor for signs of hypersensitivity, especially after the first dose. - Caution patients who operate machinery or drive, as mild drowsiness may occur. - Review all concomitant medications to prevent potential interactions.

Loratadine may interact with several drug classes; awareness helps prevent reduced efficacy or increased toxicity.

Avoid: - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) that can raise loratadine plasma levels. - Potent CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) which may affect metabolism.

Use with caution: - Alcohol, which can enhance sedation. - Other antihistamines or sedating medications, potentially increasing drowsiness. - Antacids containing aluminum or magnesium, which may reduce absorption if taken simultaneously. - Theophylline, as loratadine can modestly increase its plasma concentration.